Lipsome-encapsulated doxorubicin (MYOCET) and cyclophosphamide is superior to epirubicin and cyclophosphamide in first-line therapy of metastatic breast cancer
Year: 2001
Type: article
Source: European Journal of Cancer
Authors: S. Chan, N. Davidson, E. Juozaityte, F. Erdkamp, N. Azarnia, L.W. Lee
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2010256259